It was shown that Sinomenine significantly improved the inflammatory response of intestinal mucosa in colitis, inhibited the secretion of IL-1β and TNF-α, and improved the severity of colitis in mice by downregulating the level of miRNA-155 and other related inflammatory cytokines (Yu et al., 2013). The gene discussed is IL1B; the disease is colitis.